Taysha Gene Therapies
TSHA
TSHA
118 hedge funds and large institutions have $316M invested in Taysha Gene Therapies in 2024 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 46 increasing their positions, 16 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.93% less ownership
Funds ownership: 78.53% → 76.6% (-1.9%)
11% less capital invested
Capital invested by funds: $354M → $316M (-$38.7M)
Holders
118
Holding in Top 10
1
Calls
$55K
Puts
$50K
Top Buyers
| 1 | +$6.17M | |
| 2 | +$3.9M | |
| 3 | +$2.42M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.41M |
| 5 |
GTC
Ghost Tree Capital
New York
|
+$1.97M |
Top Sellers
| 1 | -$9.75M | |
| 2 | -$8.46M | |
| 3 | -$5.56M | |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$3.89M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$2.67M |